SCPH — Scpharmaceuticals Balance Sheet
0.000.00%
- $304.36m
- $314.75m
- $36.33m
Annual balance sheet for Scpharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 105 | 75.3 | 118 | 76 | 75.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | 4.49 | 11.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 108 | 78.3 | 123 | 92.9 | 106 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.908 | 0.479 | 0.62 | 1.46 | 1.33 |
| Other Long Term Assets | |||||
| Total Assets | 109 | 79 | 124 | 94.5 | 108 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.32 | 14.8 | 7.42 | 13.1 | 14.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.9 | 22.6 | 51.8 | 57.3 | 94.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 82.2 | 56.5 | 72.4 | 37.2 | 13.3 |
| Total Liabilities & Shareholders' Equity | 109 | 79 | 124 | 94.5 | 108 |
| Total Common Shares Outstanding |